NEWARK, Del. & UPPSALA, Sweden—-iBio, Inc. , its development collaborator, Fraunhofer USA Center for Molecular Biotechnology , and GE Healthcare, a unit of General Electric Company , today announced their entry into an agreement to jointly develop and globally market manufacturing solutions for biopharmaceuticals and vaccines based upon their respective proprietary technologies.
